Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 3

2(28.6%)

7Total

N/A(5)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02729831Not ApplicableCompleted

Comparative Effectiveness of Decision Support Strategies for Joint Replacement Surgery

Role: collaborator

NCT02339831Not ApplicableCompleted

Active Versus Passive Motion Device Following Knee Replacement Surgery

Role: collaborator

NCT02438566Phase 3Unknown

Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery

Role: lead

NCT02473198Phase 3Unknown

Femoral Nerve Block Compared to Exparel in Total Knee Replacement

Role: lead

NCT00850538Completed

Role of Bone in Knee Osteoarthritis (OA)

Role: lead

NCT01245478Withdrawn

DePuy Revision TKA Implant 5yr Survivorship

Role: lead

NCT00767559Not ApplicableUnknown

Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery

Role: lead

NCT00823888Not ApplicableCompleted

Mechanics of Knee Bracing

Role: lead

NCT00699946Not ApplicableCompleted

Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery

Role: lead

All 9 trials loaded